Cargando…
2019–2020 H1N1 clade A5a.1 viruses have better in vitro fitness compared with the co-circulating A5a.2 clade
Surveillance for emerging human influenza virus clades is important for identifying changes in viral fitness and assessing antigenic similarity to vaccine strains. While fitness and antigenic structure are both important aspects of virus success, they are distinct characteristics and do not always c...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290074/ https://www.ncbi.nlm.nih.gov/pubmed/37353648 http://dx.doi.org/10.1038/s41598-023-37122-z |
_version_ | 1785062413116112896 |
---|---|
author | Swanson, Nicholas J. Marinho, Paula Dziedzic, Amanda Jedlicka, Anne Liu, Hsuan Fenstermacher, Katherine Rothman, Richard Pekosz, Andrew |
author_facet | Swanson, Nicholas J. Marinho, Paula Dziedzic, Amanda Jedlicka, Anne Liu, Hsuan Fenstermacher, Katherine Rothman, Richard Pekosz, Andrew |
author_sort | Swanson, Nicholas J. |
collection | PubMed |
description | Surveillance for emerging human influenza virus clades is important for identifying changes in viral fitness and assessing antigenic similarity to vaccine strains. While fitness and antigenic structure are both important aspects of virus success, they are distinct characteristics and do not always change in a complementary manner. The 2019–2020 Northern Hemisphere influenza season saw the emergence of two H1N1 clades: A5a.1 and A5a.2. While several studies indicated that A5a.2 showed similar or even increased antigenic drift compared with A5a.1, the A5a.1 clade was still the predominant circulating clade that season. Clinical isolates of representative viruses from these clades were collected in Baltimore, Maryland during the 2019–2020 season and multiple assays were performed to compare both antigenic drift and viral fitness between clades. Neutralization assays performed on serum from healthcare workers pre- and post-vaccination during the 2019–2020 season show a comparable drop in neutralizing titers against both A5a.1 and A5a.2 viruses compared with the vaccine strain, indicating that A5a.1 did not have antigenic advantages over A5a.2 that would explain its predominance in this population. Plaque assays were performed to investigate fitness differences, and the A5a.2 virus produced significantly smaller plaques compared with viruses from A5a.1 or the parental A5a clade. To assess viral replication, low MOI growth curves were performed on both MDCK-SIAT and primary differentiated human nasal epithelial cell cultures. In both cell cultures, A5a.2 yielded significantly reduced viral titers at multiple timepoints post-infection compared with A5a.1 or A5a. Receptor binding was then investigated through glycan array experiments which showed a reduction in receptor binding diversity for A5a.2, with fewer glycans bound and a higher percentage of total binding attributable to the top three highest bound glycans. Together these data indicate that the A5a.2 clade had a reduction in viral fitness, including reductions in receptor binding, that may have contributed to the limited prevalence observed after emergence. |
format | Online Article Text |
id | pubmed-10290074 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-102900742023-06-25 2019–2020 H1N1 clade A5a.1 viruses have better in vitro fitness compared with the co-circulating A5a.2 clade Swanson, Nicholas J. Marinho, Paula Dziedzic, Amanda Jedlicka, Anne Liu, Hsuan Fenstermacher, Katherine Rothman, Richard Pekosz, Andrew Sci Rep Article Surveillance for emerging human influenza virus clades is important for identifying changes in viral fitness and assessing antigenic similarity to vaccine strains. While fitness and antigenic structure are both important aspects of virus success, they are distinct characteristics and do not always change in a complementary manner. The 2019–2020 Northern Hemisphere influenza season saw the emergence of two H1N1 clades: A5a.1 and A5a.2. While several studies indicated that A5a.2 showed similar or even increased antigenic drift compared with A5a.1, the A5a.1 clade was still the predominant circulating clade that season. Clinical isolates of representative viruses from these clades were collected in Baltimore, Maryland during the 2019–2020 season and multiple assays were performed to compare both antigenic drift and viral fitness between clades. Neutralization assays performed on serum from healthcare workers pre- and post-vaccination during the 2019–2020 season show a comparable drop in neutralizing titers against both A5a.1 and A5a.2 viruses compared with the vaccine strain, indicating that A5a.1 did not have antigenic advantages over A5a.2 that would explain its predominance in this population. Plaque assays were performed to investigate fitness differences, and the A5a.2 virus produced significantly smaller plaques compared with viruses from A5a.1 or the parental A5a clade. To assess viral replication, low MOI growth curves were performed on both MDCK-SIAT and primary differentiated human nasal epithelial cell cultures. In both cell cultures, A5a.2 yielded significantly reduced viral titers at multiple timepoints post-infection compared with A5a.1 or A5a. Receptor binding was then investigated through glycan array experiments which showed a reduction in receptor binding diversity for A5a.2, with fewer glycans bound and a higher percentage of total binding attributable to the top three highest bound glycans. Together these data indicate that the A5a.2 clade had a reduction in viral fitness, including reductions in receptor binding, that may have contributed to the limited prevalence observed after emergence. Nature Publishing Group UK 2023-06-23 /pmc/articles/PMC10290074/ /pubmed/37353648 http://dx.doi.org/10.1038/s41598-023-37122-z Text en © The Author(s) 2023, corrected publication 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Swanson, Nicholas J. Marinho, Paula Dziedzic, Amanda Jedlicka, Anne Liu, Hsuan Fenstermacher, Katherine Rothman, Richard Pekosz, Andrew 2019–2020 H1N1 clade A5a.1 viruses have better in vitro fitness compared with the co-circulating A5a.2 clade |
title | 2019–2020 H1N1 clade A5a.1 viruses have better in vitro fitness compared with the co-circulating A5a.2 clade |
title_full | 2019–2020 H1N1 clade A5a.1 viruses have better in vitro fitness compared with the co-circulating A5a.2 clade |
title_fullStr | 2019–2020 H1N1 clade A5a.1 viruses have better in vitro fitness compared with the co-circulating A5a.2 clade |
title_full_unstemmed | 2019–2020 H1N1 clade A5a.1 viruses have better in vitro fitness compared with the co-circulating A5a.2 clade |
title_short | 2019–2020 H1N1 clade A5a.1 viruses have better in vitro fitness compared with the co-circulating A5a.2 clade |
title_sort | 2019–2020 h1n1 clade a5a.1 viruses have better in vitro fitness compared with the co-circulating a5a.2 clade |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290074/ https://www.ncbi.nlm.nih.gov/pubmed/37353648 http://dx.doi.org/10.1038/s41598-023-37122-z |
work_keys_str_mv | AT swansonnicholasj 20192020h1n1cladea5a1viruseshavebetterinvitrofitnesscomparedwiththecocirculatinga5a2clade AT marinhopaula 20192020h1n1cladea5a1viruseshavebetterinvitrofitnesscomparedwiththecocirculatinga5a2clade AT dziedzicamanda 20192020h1n1cladea5a1viruseshavebetterinvitrofitnesscomparedwiththecocirculatinga5a2clade AT jedlickaanne 20192020h1n1cladea5a1viruseshavebetterinvitrofitnesscomparedwiththecocirculatinga5a2clade AT liuhsuan 20192020h1n1cladea5a1viruseshavebetterinvitrofitnesscomparedwiththecocirculatinga5a2clade AT fenstermacherkatherine 20192020h1n1cladea5a1viruseshavebetterinvitrofitnesscomparedwiththecocirculatinga5a2clade AT rothmanrichard 20192020h1n1cladea5a1viruseshavebetterinvitrofitnesscomparedwiththecocirculatinga5a2clade AT pekoszandrew 20192020h1n1cladea5a1viruseshavebetterinvitrofitnesscomparedwiththecocirculatinga5a2clade |